Monaldi Archives for Chest Disease
Scope & Guideline
Unlocking the Secrets of Cardiovascular and Respiratory Wellness
Introduction
Aims and Scopes
- Pulmonary Diseases Research:
The journal emphasizes research on various pulmonary conditions, including tuberculosis, chronic obstructive pulmonary disease (COPD), asthma, and interstitial lung diseases, contributing significantly to understanding these diseases' pathophysiology, diagnosis, and management. - Cardiovascular Health Studies:
Research related to cardiovascular diseases, including heart failure, myocardial infarction, and arrhythmias, is a core area. The journal publishes studies that explore the intersection of respiratory and cardiac health, particularly in complex cases. - Infectious Diseases and Public Health:
There is a strong focus on infectious diseases, especially tuberculosis and COVID-19, reflecting the journal's commitment to addressing global health challenges and providing insights into treatment protocols and public health strategies. - Innovative Therapeutic Approaches:
The journal highlights studies on new therapeutic interventions, including pharmacological treatments, rehabilitation strategies, and innovative surgical techniques, aimed at improving patient outcomes in respiratory and cardiovascular care. - Clinical and Epidemiological Studies:
Monaldi Archives prioritizes epidemiological research that informs clinical practice, assessing risk factors, treatment outcomes, and healthcare delivery models to enhance understanding and management of chest diseases.
Trending and Emerging
- COVID-19 Impact and Management:
The journal has seen a surge in studies focused on the effects of COVID-19 on respiratory and cardiovascular health, including post-acute sequelae, treatment strategies, and healthcare system responses, indicating a major shift in research focus due to the pandemic. - Telemedicine and Remote Patient Management:
With the rise of telehealth during the pandemic, there is an emerging trend in studies evaluating the effectiveness of telemedicine in managing chronic respiratory and cardiovascular diseases, showcasing innovative approaches to patient care. - Multidisciplinary Approaches to Treatment:
There is a growing emphasis on multidisciplinary treatment strategies that integrate various specialties, such as pulmonology, cardiology, and rehabilitation, in managing complex patients, reflecting a trend towards holistic patient care. - Environmental and Socioeconomic Factors:
Research exploring the impact of environmental factors, such as air pollution, on respiratory diseases has gained traction, highlighting the importance of understanding social determinants of health in managing chest diseases. - Personalized Medicine and Biomarkers:
There is an increasing focus on personalized medicine, including studies on biomarkers for disease prediction and treatment response, showcasing a shift towards tailored therapeutic strategies in respiratory and cardiovascular care.
Declining or Waning
- Traditional Surgical Techniques:
There has been a noticeable decrease in studies focusing solely on traditional surgical techniques for respiratory diseases, possibly due to the rise of minimally invasive and endoscopic methods that are gaining preference in clinical practice. - Basic Science and Laboratory Studies:
Research focusing on basic science aspects of pulmonary and cardiovascular diseases is less prevalent, as the journal increasingly emphasizes clinical and translational studies that directly impact patient care. - Longitudinal Studies in Chronic Diseases:
The frequency of longitudinal studies examining chronic respiratory or cardiac conditions has waned, potentially reflecting a shift towards more immediate, short-term outcome studies in the context of recent global health crises.
Similar Journals
Pulmonary Medicine
Championing Open Access for Global Health SolutionsPulmonary Medicine, published by HINDAWI LTD, stands as a prestigious open-access journal since 2010, dedicated to advancing the field of pulmonary and respiratory medicine. Located in Egypt, this journal is indexed with an ISSN of 2090-1836 and an E-ISSN of 2090-1844, and it has attained a commendable Q2 ranking in both the miscellaneous medicine and pulmonary health categories, indicative of its significant impact and quality. With an impressive Scopus ranking of #15 out of 155 in the pulmonary and respiratory medicine category, the journal is positioned in the 90th percentile, highlighting its relevance and contribution to ongoing research. The journal aims to publish high-quality original research, reviews, and clinical studies that address pressing issues in pulmonary health, making it a vital resource for researchers, clinicians, and students seeking to enhance their understanding and practice in respiratory medicine. By embracing an open-access model, Pulmonary Medicine provides a platform for disseminating knowledge, fostering collaboration, and driving innovation within the global scientific community.
Clinical Medicine Insights-Circulatory Respiratory and Pulmonary Medicine
Bridging Research and Practice in Pulmonary MedicineClinical Medicine Insights-Circulatory Respiratory and Pulmonary Medicine, published by SAGE Publications Ltd, stands as a vital resource in the fields of Cardiology and Pulmonary Medicine, underscored by its Q3 quartile rankings in both areas for 2023. Established in 2007 as an open-access journal, it facilitates the dissemination of cutting-edge research and observations from the international scientific community. With an ISSN of 1179-5484, the journal has garnered recognition for its contributions to clinical medicine, particularly covering topics of circulatory, respiratory, and pulmonary health. The journal not only aims to bridge the gap between research and clinical practice but also to serve as a platform for innovative ideas and collaborations among researchers, healthcare professionals, and trainees. By offering unrestricted access to its articles, Clinical Medicine Insights ensures that vital knowledge reaches a broad audience, ultimately fostering advancements in medical science and patient care.
Canadian Journal of Respiratory Critical Care and Sleep Medicine
Advancing knowledge in respiratory and critical care.Welcome to the Canadian Journal of Respiratory Critical Care and Sleep Medicine, a prestigious peer-reviewed journal published by Taylor & Francis Inc. With an ISSN of 2474-5332 and an E-ISSN of 2474-5340, this journal serves as a vital platform for disseminating cutting-edge research in the fields of critical care, intensive care medicine, and pulmonary and respiratory medicine. Since its inception in 2017, the journal has established itself within the academic community, currently holding a Q2 ranking in Critical Care and Intensive Care Medicine and a Q3 ranking in Pulmonary and Respiratory Medicine for 2023. Although it operates under a standard access model, the journal remains committed to providing valuable insights and advancing knowledge through rigorous research articles, reviews, and case studies. Positioned in the heart of the United States, the journal aims to foster collaboration and innovation among healthcare professionals, researchers, and students dedicated to enhancing respiratory care and critical treatment protocols. Join us in exploring the dynamic intersection of research and practice that defines our mission.
RESPIROLOGY
Setting the Standard in Respiratory ResearchRESPIROLOGY is a prestigious academic journal that focuses on the field of Pulmonary and Respiratory Medicine, publishing high-quality research and comprehensive reviews that contribute significantly to the understanding and management of respiratory health. As a distinguished publication of WILEY, it has established a strong presence in the academic world with an impressive impact factor and ranked in the Q1 category, recognized for its influence and innovation in the field. RESPIROLOGY is committed to disseminating cutting-edge research from 1996 through 2024, appearing regularly in SCOPUS with a rank of #14 out of 155, placing it in the rarefied 91st percentile among its peers. The journal invites contributions from researchers, professionals, and students, fostering a collaborative space for advancing knowledge in pulmonary medicine. Although it does not offer open access, its readership spans globally, indicating the high regard in which it is held within the scientific community.
Tuberculosis and Respiratory Diseases
Fostering innovation in pulmonary medicine.Tuberculosis and Respiratory Diseases is a leading open-access journal published by THE KOREAN ACADEMY OF TUBERCULOSIS & RESPIRATORY DISEASES, dedicated to disseminating knowledge in the fields of infectious diseases and pulmonary medicine. Since its inception in 1980, the journal has undergone significant growth, currently recognized in the elite Q2 category for both Infectious Diseases and Pulmonary and Respiratory Medicine as of 2023. With an impact factor reflecting its esteemed position—ranked 52nd in its category—it serves as a vital resource for researchers and healthcare professionals seeking cutting-edge insights, studies, and advancements in the management and treatment of respiratory diseases, particularly tuberculosis. The journal is committed to providing open access to its content since 2013, ensuring that critical research is available to scholars worldwide, fostering collaboration and innovation in the global fight against respiratory illnesses.
Thoracic Research and Practice
Driving Innovation in Thoracic Health and ResearchThoracic Research and Practice is an emerging open access journal published by AVES that aims to advance knowledge in the field of pulmonary and respiratory medicine. Launched in 2022, this journal aspires to provide a platform for innovative research, clinical practices, and advancements in thoracic health. With an E-ISSN of 2979-9139, it caters to a global audience while based in Turkey. Although it currently holds a Q4 category in the 2023 ranking within its field, the journal is dedicated to improving its standing through the inclusion of high-quality, original articles, systematic reviews, and case studies. As it converges years from 2023 to 2024, Thoracic Research and Practice invites researchers, professionals, and students to contribute valuable insights that aim to enhance patient outcomes and propel further exploration in this critical area of medicine.
BASIC RESEARCH IN CARDIOLOGY
Shaping the future of cardiology with impactful studies.BASIC RESEARCH IN CARDIOLOGY, published by SPRINGER HEIDELBERG, is an esteemed peer-reviewed journal dedicated to advancing the field of cardiology and cardiovascular medicine since 1973. With a strong emphasis on the latest breakthroughs in basic and translational research, this journal offers a platform for high-quality, impactful studies that contribute to our understanding of cardiac function and related physiological processes. Currently ranked in the Q1 category in Cardiology and Cardiovascular Medicine, as well as Physiology and Medical Physiology, BASIC RESEARCH IN CARDIOLOGY is recognized as a leading journal within these disciplines, boasting impressive Scopus ranks that place it in the top tiers of global research output. While it does not offer open access, its contributions are pivotal for researchers, clinicians, and students seeking to stay abreast of cutting-edge discoveries and methodologies in cardiovascular science. With its commitment to scholarly excellence, this journal plays a critical role in shaping the future of cardiac research and clinical practice.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
Pioneering research for a healthier respiratory future.American Journal of Respiratory and Critical Care Medicine, published by the American Thoracic Society, is a leading scholarly journal dedicated to advancing the fields of critical care and pulmonary medicine. With an impressive impact factor and recognized in the Q1 quartile for both Critical Care and Pulmonary Medicine, this journal is essential reading for researchers, clinicians, and students invested in innovative practices and therapies in respiratory health. Through high-quality, peer-reviewed research articles, the journal addresses significant contemporary issues in respiratory and critical care, offering unparalleled insights and fostering interdisciplinary collaboration. Although the journal adheres to a traditional subscription model, it remains a cornerstone for those wishing to stay at the forefront of medical science in this vital area. With its extensive historical context since its establishment in 1991 and continuous publication spanning through 2024, the journal is committed to promoting discourse and disseminating knowledge that ultimately enhances patient care and clinical outcomes.
RESPIRATION
Advancing the Frontiers of Pulmonary MedicineRESPIRATION is a prestigious journal dedicated to advancing knowledge in the field of Pulmonary and Respiratory Medicine, with a commitment to publishing high-quality, peer-reviewed research. Established in 1944 and published by KARGER in Switzerland, this journal has maintained an exemplary impact within the scientific community, currently holding a Q1 ranking in the 2023 category for Pulmonary and Respiratory Medicine, placing it among the top 18% of journals in its field. With an ISSN of 0025-7931 and an E-ISSN of 1423-0356, RESPIRATION provides a platform for researchers and professionals to disseminate original studies, reviews, and clinical cases that shape contemporary understanding and treatment of respiratory diseases. The journal's rigorous standards for publication ensure that it remains a vital resource for the latest innovations and findings. As part of its mission, RESPIRATION seeks to bridge the gap between clinical practice and research, fostering multidisciplinary collaboration and enhancing patient outcomes. The journal is readily accessible, ensuring that vital research reaches a broad audience of healthcare professionals and academic scholars globally.
Annals of Thoracic Medicine
Connecting researchers and practitioners in thoracic health.Annals of Thoracic Medicine is a prominent open-access journal, published by Wolters Kluwer Medknow Publications, focusing on the critical fields of cardiology, pulmonary and respiratory medicine, and surgery. With an ISSN of 1817-1737 and an E-ISSN of 1998-3557, this journal aims to disseminate cutting-edge research, clinical findings, and innovative practices that can significantly impact the health outcomes of patients dealing with thoracic diseases. Since its inception in 2006, it has established itself as a reputable source of knowledge, achieving Q2 quartile rankings in 2023 across its main categories. Currently ranked #126 in Medicine & Surgery and exhibiting a growing SCOPUS percentile, the journal plays an essential role in advancing the understanding and treatment of thoracic conditions. Open access options ensure that research is readily available to a global audience, facilitating collaboration and knowledge sharing among researchers, healthcare professionals, and students in the field.